These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7285624)

  • 41. [Methotrexate-induced liver cirrhosis in psoriasis. Determination of tissue type and histopathological assessment].
    Zachariae H; Kissmeyer-Nielsen F; Kragballe K; Thestrup-Pedersen K; Søgaard H
    Ugeskr Laeger; 1980 Aug; 142(34):2182-4. PubMed ID: 7423637
    [No Abstract]   [Full Text] [Related]  

  • 42. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug reactions XV. Methotrexate, psoriasis and the liver.
    Almeyda J; Barnardo D; Baker H
    Br J Dermatol; 1971 Sep; 85(3):302-5. PubMed ID: 4939241
    [No Abstract]   [Full Text] [Related]  

  • 47. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity.
    McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D
    Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage.
    Rademaker M; Webb JA; Lowe DG; Meyrick-Thomas RH; Kirby JD; Munro DD
    Br J Dermatol; 1987 Sep; 117(3):311-6. PubMed ID: 3676081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.
    Robinson JK; Baughman RD; Auerbach R; Cimis RJ
    Arch Dermatol; 1980 Apr; 116(4):413-5. PubMed ID: 7369769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cirrhosis following methotrexate administration for psoriasis.
    Coughlin GP; Henderson DW; Reid JG; Grant AK
    Med J Aust; 1973 Sep; 2(10):499-501. PubMed ID: 4750546
    [No Abstract]   [Full Text] [Related]  

  • 51. Methotrexate in psoriasis: revised guidelines.
    Roenigk HH; Auerbach R; Maibach HI; Weinstein GD
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):145-56. PubMed ID: 3042816
    [No Abstract]   [Full Text] [Related]  

  • 52. Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.
    Menting SP; Dekker PM; Limpens J; Hooft L; Spuls PI
    Acta Derm Venereol; 2016 Jan; 96(1):23-8. PubMed ID: 25721372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy.
    Hanno R; Gruber GG; Owen LG; Callen JP
    J Am Acad Dermatol; 1980 Feb; 2(2):171-4. PubMed ID: 7364974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Apropos of 2 accidents during general treatments with methotrexate].
    Amblard P; Dugois P; Imbert R; Fillon JP; Martel J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):85-7. PubMed ID: 5565944
    [No Abstract]   [Full Text] [Related]  

  • 55. Complete recovery of complicated methotrexate-induced liver cirrhosis in a patient with psoriasis: A case report.
    El Hage S; Akiki D; El Masri J; Roustom M
    Transpl Immunol; 2022 Feb; 70():101492. PubMed ID: 34767946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate, alcohol, and liver damage.
    Almeyda J; Baker H; Levene GM; Barnardo D; Landells JW
    Br Med J; 1971 Apr; 2(5754):167. PubMed ID: 5581500
    [No Abstract]   [Full Text] [Related]  

  • 57. Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate.
    Orr A; Parker R
    Menopause Int; 2013 Sep; 19(3):133-4. PubMed ID: 24072635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methotrexate guidelines--revised.
    Roenigk HH; Auerbach R; Maibach HI; Weinstein GD
    J Am Acad Dermatol; 1982 Feb; 6(2):145-55. PubMed ID: 7037877
    [No Abstract]   [Full Text] [Related]  

  • 59. Methotrexate.
    Lester RS
    Clin Dermatol; 1989; 7(3):128-35. PubMed ID: 2680016
    [No Abstract]   [Full Text] [Related]  

  • 60. Parenteral methotrexate in psoriasis. A report on the efficacy and toxicity of long-term intermittent treatment.
    McDonald CJ; Bertino JR
    Arch Dermatol; 1969 Dec; 100(6):655-68. PubMed ID: 4243752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.